3. Old stuff
          3.2. Old physio stuff (around 2005)
              3.2.3. Physiology
                  3.2.3.6. Haematology
                      3.2.3.6.1. Blood cells
                          3.2.3.6.1.3. Red blood cells
                              3.2.3.6.1.3.1. Haemoglobin
 3.2.3.6.1.3.1.1. Methaemoglobin 

Methaemoglobin (MetHb)

[Ref: JN5:p272-273; WG21:p536-539; KB:p211]

In MetHb,

Iron is ferric (Fe3+) instead of ferrous (Fe2+)

Characteristics

  • Dark coloured
  • Unable to combine with oxygen
  • Causes cyanosis when MetHb > 1.5g/dL
    * Cyanosis only occurs when DeoxyHb > 5g/dL
  • Normally MetHb is about 1-2% of total Hb
    * ?? Reference

Formation

  • When oxyhaemoglobin acts as nitric oxide (NO) scavenger
  • Drugs
    * e.g. prilocaine, benzocaine, nitrites, dapsone

Reduction

Iron is reduced back to ferrous
--> MetHb converted back to Hb

By 4 systems:

1. NADH-methaemoglobin reductase system

  • Present in RBC
  • Uses NADH provided by Embden-Meyerhof pathway
  • Accounts for 2/3 of MetHb-reducing activities
  • Deficient in familial methaemoglobinaemia

2. Ascorbic acid

May slowly reduce the iron by direct chemical effect

Accounts for 16% of MetHb reduction

3. Glutathione-based reductive enzymes

Small amount of MetHb reductase activity

4. NADPH-dehydrogenase enzyme in RBC

  • Can reduce MetHb using NADPH from pentose phosphate pathway
  • Under normal condition, this system has almost no effect
  • Regarded as a reserve mechanism

 

NB:

[KB2:p137]

In presence of methylene blue, activity of NADPH-MetHb reductase (?? same as NADPH-dehydrogenase) increases
--> NADPH-MetHb reductase reduces methylene blue
--> Reduced form of methylene blue reduces MetHb